Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Clinical trial NCT02098109 · COMPLETED

Trial details

NCT number: NCT02098109
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Lymphoma, Non-Hodgkin

Start date: 2014-08-20
Primary completion: 2016-06-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.